Skip to main content
HYPD
NASDAQ Life Sciences

CFO David Knox Buys Over $100K in HYPD Stock, Signaling Strong Confidence

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$3.636
Mkt Cap
$29.258M
52W Low
$0.85
52W High
$17.992
52W Position info
328% above low
Off High info
80% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

HYPD has more than doubled off its 52-week low of $0.85.

Summary

HYPERION DEFI's Chief Financial Officer, David Knox, made a significant open market purchase of company stock, investing over $100,000. This transaction signals strong insider confidence in the company's future.


Key Events · Ownership and Investor Activity · HYPD

  • CFO Open Market Purchase

    David Knox, the Chief Financial Officer, acquired 27,950 shares of common stock for a total of $100,340.50 in an open market transaction on December 31, 2025.

  • Increased Insider Holdings

    Following this purchase, Mr. Knox's direct holdings in HYPERION DEFI, INC. increased to 327,950 shares.

  • Strong Insider Confidence

    This significant investment by a key executive indicates strong confidence in the company's performance and future outlook.


Analysis · HYPD · Life Sciences

The Chief Financial Officer's direct purchase of over $100,000 worth of common stock is a notable vote of confidence, especially given the company's nano-cap status. Such an investment by a key executive suggests a belief in the company's intrinsic value and future prospects. Investors often view substantial insider buying as a positive indicator, as executives typically have the most intimate knowledge of the company's operations and outlook.

How filings like this one have moved

In the 30 days to Sep 14, 2026, 35.8% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, HYPD was trading at $3.64 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $29.3M. The 52-week trading range was $0.85 to $17.99. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HYPD - Latest Insights

HYPD
Sep 08, 2026, 8:12 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $3.41
Real-time Price: $3.49 info
Change: +$0.0843 (+2%) info
Market Cap: $54.233M info
HYPD
Aug 12, 2026, 8:15 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.83
Real-time Price: $3.49 info
Change: +$0.660 (+23%) info
Market Cap: $54.233M info
HYPD
Aug 12, 2026, 5:19 PM EDT
Source: The Block
Importance Score:
7
Price at Filing: $2.82
Real-time Price: $3.49 info
Change: +$0.670 (+24%) info
Market Cap: $54.233M info
HYPD
Aug 12, 2026, 4:15 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $2.82
Real-time Price: $3.49 info
Change: +$0.6659 (+24%) info
Market Cap: $54.233M info
HYPD
Aug 12, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.79
Real-time Price: $3.49 info
Change: +$0.700 (+25%) info
Market Cap: $54.233M info